Literature DB >> 1329685

Surgical treatment for higher stage non-small cell lung cancer.

D E Van Raemdonck1, A Schneider, R J Ginsberg.   

Abstract

Locally advanced lung cancer (stage IIIa, IIIb) in which the primary tumor is proximal (T3) or has invaded adjacent structures (T3) or organs (T4) or in which mediastinal lymph nodes are involved (N2, N3) worsens the prognosis significantly. However, in stage IIIa (T3 or N2), when surgical treatment results in total removal of the primary tumor and involved lymph nodes, there still is a reasonable chance for ultimate cure. On the other hand, total excision can be very rarely performed in T4 or N3 tumors. Therefore, this group (stage IIIb) usually indicates unresectability. Disseminated lung cancer with distant metastasis (stage IV) is still considered to be incurable. Nevertheless, solitary metastatic sites (M1), especially brain, have been treated on occasion by resection of the primary tumor and removal of the solitary metastasis. This appears to improve median survival and does yield 5-year survival in selected patients. The results after surgical treatment in these patients with higher stage lung cancer reported over the last 10 years are reviewed.

Entities:  

Mesh:

Year:  1992        PMID: 1329685     DOI: 10.1016/0003-4975(92)90677-v

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Video-assisted mediastinal lymph node dissection assessed in an experimental setting.

Authors:  M Furrer; H J Altermatt; H B Ris; D Mettler; U Althaus
Journal:  Surg Endosc       Date:  1996-02       Impact factor: 4.584

2.  Extended operation for non-small-cell lung cancer invading into the liver.

Authors:  K Sakamoto; T Suda; K Ide
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-07

3.  Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases.

Authors:  T Fukuse; T Hirata; H Naiki; S Hitomi; H Wada
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

Review 4.  Extended resection for higher-stage non-small-cell lung cancer.

Authors:  J D Luketich; D E van Raemdonck; R J Ginsberg
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

5.  Management and surgical resection for tumors of the trachea and carina: experience with 32 patients.

Authors:  Xiang-Yan Liu; Fan-Ying Liu; Zhou Wang; Gang Chen
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

6.  Stereotactic body radiotherapy for T3 and T4N0M0 non-small cell lung cancer.

Authors:  Takahisa Eriguchi; Atsuya Takeda; Naoko Sanuki; Shuichi Nishimura; Yoshiaki Takagawa; Tatsuji Enomoto; Noriyuki Saeki; Kae Yashiro; Tomikazu Mizuno; Yousuke Aoki; Yohei Oku; Tetsuya Yokosuka; Naoyuki Shigematsu
Journal:  J Radiat Res       Date:  2016-03-16       Impact factor: 2.724

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.